<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Berger S</dc:creator>
  <dc:creator>Schad T</dc:creator>
  <dc:creator>von Wyl V</dc:creator>
  <dc:creator>Ehlert U</dc:creator>
  <dc:creator>Zellweger C</dc:creator>
  <dc:creator>Furrer H</dc:creator>
  <dc:creator>Regli D</dc:creator>
  <dc:creator>Vernazza P</dc:creator>
  <dc:creator>Ledergerber B</dc:creator>
  <dc:creator>Battegay M</dc:creator>
  <dc:creator>Weber R</dc:creator>
  <dc:creator>Gaab J</dc:creator>
  <dc:date>2008</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">OBJECTIVE
To determine the effects of cognitive-behavioral stress management (CBSM) training on clinical and psychosocial markers in HIV-infected persons.


METHODS
A randomized controlled trial in four HIV outpatient clinics of 104 HIV-infected persons taking combination antiretroviral therapy (cART), measuring HIV-1 surrogate markers, adherence to therapy and well-being 12 months after 12 group sessions of 2 h CBSM training.


RESULTS
Intent-to-treat analyses showed no effects on HIV-1 surrogate markers in the CBSM group compared with the control group: HIV-1 RNA &lt; 50 copies/ml in 81.1% [95% confidence interval (CI), 68.0-90.6] and 74.5% (95% CI, 60.4-85.7), respectively (P = 0.34), and mean CD4 cell change from baseline of 53.0 cells/microl (95% CI, 4.1-101.8) and 15.5 cells/microl (95% CI, -34.3 to 65.4), respectively (P = 0.29). Self-reported adherence to therapy did not differ between groups at baseline (P = 0.53) or at 12 month's post-intervention (P = 0.47). Significant benefits of CBSM over no intervention were observed in mean change of quality of life scores: physical health 2.9 (95% CI, 0.7-5.1) and -0.2 (95% CI, -2.1 to 1.8), respectively (P = 0.05); mental health 4.8 (95% CI, 1.8-7.3) and -0.5 (95% CI, -3.3 to 2.2) (P = 0.02); anxiety -2.1 (95% CI, -3.6 to -1.0) and 0.3 (95% CI, -0.7 to 1.4), respectively (P = 0.002); and depression -2.1 (95% CI, -3.2 to -0.9) and 0.02 (95% CI, -1.0 to 1.1), respectively (P = 0.001). Alleviation of depression and anxiety symptoms were most pronounced among participants with high psychological distress at baseline.


CONCLUSION
CBSM training of HIV-infected persons taking on cART does not improve clinical outcome but has lasting effects on quality of life and psychological well-being.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/4390</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1097/QAD.0b013e3282f511dc</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/18356607</dc:relation>
  <dc:source>AIDS (London, England). - 2008</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Adult</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Anti-HIV Agents</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Behavior Therapy</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">CD4 Lymphocyte Count</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Cognitive Behavioral Therapy</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Combined Modality Therapy</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Female</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">HIV Infections</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">HIV-1</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Male</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Middle Aged</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Psychometrics</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">RNA, Viral</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Stress, Psychological</dc:subject>
  <dc:title xmlns:ns16="xml" ns16:lang="en">Effects of cognitive behavioral stress management on HIV-1 RNA, CD4 cell counts and psychosocial parameters of HIV-infected persons.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
